Cargando…
Large-scale Clinical-grade Retroviral Vector Production in a Fixed-Bed Bioreactor
The successful genetic engineering of patient T cells with γ-retroviral vectors expressing chimeric antigen receptors or T-cell receptors for phase II clinical trials and beyond requires the large-scale manufacture of high-titer vector stocks. The production of retroviral vectors from stable packagi...
Autores principales: | Wang, Xiuyan, Olszewska, Malgorzata, Qu, Jinrong, Wasielewska, Teresa, Bartido, Shirley, Hermetet, Gregory, Sadelain, Michel, Rivière, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353472/ https://www.ncbi.nlm.nih.gov/pubmed/25751502 http://dx.doi.org/10.1097/CJI.0000000000000072 |
Ejemplares similares
-
Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor
por: Valkama, A J, et al.
Publicado: (2018) -
How do CARs work?: Early insights from recent clinical studies targeting CD19
por: Davila, Marco L., et al.
Publicado: (2012) -
Viral vector production in the integrity(® )iCELLis(® )single-use fixed-bed bioreactor, from bench-scale to industrial scale
por: Lennaertz, Alexandre, et al.
Publicado: (2013) -
Optimizing and developing a scalable, chemically defined, animal component-free lentiviral vector production process in a fixed-bed bioreactor
por: Fiol, Carme Ripoll, et al.
Publicado: (2023) -
Chemical Enhancement for Retrofitting Moving Bed Biofilm and Integrated Fixed Film Activated Sludge Systems into Membrane Bioreactors
por: Maletskyi, Zakhar, et al.
Publicado: (2019)